Endorphin Agonists for Severe Depression
Pharmacy & Pharmacology International Journal · 2015
DOI: 10.15406/ppij.2015.02.00017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy & Pharmacology International Journal, 2015. Verfasst von Alen J Salerian. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Endorphins and endorphin agonists play a crucial role in the neural modulation of mood, anxiety, pain and addiction. Recent studies have elucidated the crucial mechanism of enhancing prefrontal cortex influence and dampening limbic and sub cortical influences in depression and remission consistent with the biological profile of endorphin agonists. The historical, biological, experimental and clinical data strongly support the potential benefits of opiates for severe depression. Further research to study endorphin agonists for depression and possibly for other psychiatric disorders seems warranted.
Zitieren
APA
Salerian, A. J. (2015). Endorphin Agonists for Severe Depression. Pharmacy & Pharmacology International Journal. https://doi.org/10.15406/ppij.2015.02.00017
Vancouver
Salerian AJ. Endorphin Agonists for Severe Depression. Pharmacy & Pharmacology International Journal. 2015. doi:10.15406/ppij.2015.02.00017
BibTeX
@article{Salerian2015,
author = {Salerian, Alen J},
title = {Endorphin Agonists for Severe Depression},
journal = {Pharmacy & Pharmacology International Journal},
year = {2015},
doi = {10.15406/ppij.2015.02.00017}
}
EUVIMED